Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Naveris Raises $51M Series A

2022-09-19
NATICK, MA, Naveris, Inc., a commercial-stage life sciences company, announced a $33.4 million expansion of its Series A financing.
Naveris, Inc., a commercial-stage life sciences company dedicated to improving patient care through earlier detection of viral-driven cancers, announced a $33.4 million expansion of its Series A financing, bringing the total investment in Naveris to $51 million.

The financing was led by Gurnet Point Capital, joined by TechU Ventures and BrightEdge, the impact and venture capital arm of the American Cancer Society.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors